Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Akoya Biosciences Q3 EPS $(0.26) Beats $(0.37) Estimate, Sales $25.21M Beat $24.54M Estimate

Author: Benzinga Newsdesk | November 08, 2023 05:42pm
Akoya Biosciences (NASDAQ:AKYA) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(0.37) by 29.73 percent. This is a 44.68 percent increase over losses of $(0.47) per share from the same period last year. The company reported quarterly sales of $25.21 million which beat the analyst consensus estimate of $24.54 million by 2.75 percent. This is a 33.75 percent increase over sales of $18.85 million the same period last year.

Posted In: AKYA


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist